DJ Wood

Associate Vice President, Global Scientific Communications and Publications - Solid Tumors at Stemline Therapeutics

DJ Wood has over 25 years of work experience in the pharmaceutical and healthcare industry. DJ is currently working at Stemline Therapeutics as the Associate Vice President of Global Scientific Communications and Publications for Solid Tumors. Prior to this role, they worked at Novartis Oncology from 2008 to 2023, holding various positions including Executive Director / Worldwide Head of Scientific Engagement, Executive Director / Head of US Scientific Communications, and Sr. Director / Head of US Scientific Communications.

Before joining Novartis, DJ Wood worked at Merck as the National Director of Field Medical from 2005 to 2008, and at Sanofi as a Sr. Regional Medical Manager from 2003 to 2005. DJ also had experience at InterMune, where they served as the National Director of Field Medical and as a Medical Science Liaison from 2000 to 2003.

Earlier in their career, DJ Wood held the position of Clinical Coordinator at Western Maryland Health System, Clinical Pharmacist at Duke University Health System, and Staff Pharmacist at Novant Health.

DJ Wood's education history begins in 1990 when they attended the University of North Carolina at Chapel Hill, where they pursued a Bachelor of Science in Pharmacy. They completed their undergraduate degree in 1996. Following this, in 1996-1997, DJ Wood continued their education at the same institution, earning a Doctor of Pharmacy degree. In 2009, they enrolled at Drexel University's LeBow College of Business to pursue a Master of Business Administration (MBA) with a focus on Finance. Their MBA studies concluded in 2011. Lastly, in 2020, DJ Wood attended Harvard Medical School. Although no specific degree or field of study is mentioned for this study period, it indicates their continuing education and interest in the medical field.

Links

Previous companies

Merck logo
UPMC logo
Sanofi logo

Timeline

  • Associate Vice President, Global Scientific Communications and Publications - Solid Tumors

    February, 2023 - present

View in org chart